Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000932352-17-000002
Filing Date
2017-04-13
Accepted
2017-04-13 12:28:55
Documents
1
Effectiveness Date
2017-04-13
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7484
  Complete submission text file 0000932352-17-000002.txt   8775
Mailing Address 501 SILVERSIDE ROAD PMB#95 WILMINGTON DE 19809
Business Address 501 SILVERSIDE ROAD PMB#95 WILMINGTON DE 19809 (925) 280-2861
Urigen Pharmaceuticals, Inc. (Filer) CIK: 0000932352 (see all company filings)

EIN.: 943156660 | State of Incorp.: DE | Fiscal Year End: 0630
Type: D | Act: 33 | File No.: 021-284723 | Film No.: 17760008
SIC: 2834 Pharmaceutical Preparations